4basebio

(4BB)
Sector: Pharmaceuticals & Biotechnology
1,316.67p
16.67p 1.28
Last updated: 11:00:10

Share information

Name 4basebio
Epic 4BB
Isin GB00BMCLYF79
Index MID300
Industry Pharmaceuticals & Biotechnology

Key numbers

Latest share price 1,316.67p Net gearing n/a
Market capitalisation £203.79 Debt ratio n/a
Shares in issue 12.81 Debt-to-equity ratio n/a
P/E ratio n/a Assets / equity ratio n/a
Total dividends per share n/a Price to book value n/a
Dividend yield n/a ROCE -69.97
Dividend cover n/a EPS growth n/a
Earning per share -42 52-week high / low 545.00p / 1,820.00p

Dividends

Type Ex-date Pay-date Net-dividend
No dividends declared

Contact details

Company name 4basebio
Address 25 Norman Way, Over, Cambridge, United Kingdom, CB24 5QE
Telephone +44 (0)1223 967943
Website http://www.4basebio.com/

Directors

Director Position
Dr Heikki Lanckriet CEO
Mr David John Roth CFO
Mr Hansjörg Plaggemars Non-Executive Director
Mr Joseph Manuel Fernández Non-Executive Director
Mr Timothy Paul McCarthy Non-Executive Chairman
Mr Maria Del Pilar de la Huerta Independent Non-Executive Director

Company financials

Assets £ (m) 2022 2021 2020
Reporting date 31/12/22 31/12/21 31/12/20
Intangible asssets and goodwill 2.12 1.27 0.79
Investments and other non-current assets n/a n/a n/a
Total non-current assets 5.79 4.06 2.3
Inventory / work in progress 0.13 0.16 0.13
Trade and other receivables 0.05 0.05 0.04
Cash and equivalents 4.35 9.59 15
Other current assets and asset held for resale 1.36 0.85 0.34
Total of all assets 11.69 14.7 17.81
Liabilities £ (m) 2022 2021 2020
Short term liabilities 1.52 1.52 0.81
Long term liabilities 3.05 1.48 1.54
Other liabilites / pension etc n/a n/a n/a
Total of all liabilities 4.57 3.01 2.35
Net assets £ (m) 2022 2021 2020
Net assets 7.12 11.7 15.46
Equity £ (m) 2022 2021 2020
Share capital 11.13 11.13 11.13
Minority interests n/a n/a n/a
Retained earnings -18.73 -13.57 -10.34
Share premium account 0.71 0.71 0.71
Total equity 7.12 11.7 15.46
Income £ (m) 2022 2021 2020
Turnover n/a n/a n/a
Operating profit -5.84 -3.53 -0.62
Pre-tax profit -5.93 -3.64 -0.72